Alerts will be sent to your verified email
Verify Email
FREDUN
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Fredun Pharmaceuticals Limited is a trusted manufacturer of pharmaceutical products, dietary supplements, nutraceuticals, and healthcare products in Africa, Southeast Asia, CIS countries, and Latin America, aiming to be a holistic healthcare provider.
Fredun Pharma major competitors are Medicamen Biotech, Albert David, Jenburkt Pharma, Brooks Laboratories, Zim Laboratories, Prevest Denpro, Lyka Labs.
Market Cap of Fredun Pharma is ₹509 Crs.
While the median market cap of its peers are ₹464 Crs.
Fredun Pharma seems to be less financially stable compared to its competitors.
Altman Z score of Fredun Pharma is 4.01 and is ranked 6 out of its 8 competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | May Jul | Mar Dec | Mar | Mar Jun Sep Dec | Sep | |||||||||||||
| Investor Presentation | Jun | Dec | Dec | Mar | ||||||||||||||
| Conference Call | Jun | |||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
